Lifetime Achievement Award in Clinical Research

Josep Tabernero

Director of the Vall d'Hebron Institute of Oncology and Head of the Molecular Cancer Therapy Research Unit at the Vall d'Hebron Hospital (VHIO)

“The Lifetime Achievement Award in Clinical Research recognizes researchers who have dedicated their careers to clinical research in oncology, infectious diseases, and inflammatory conditions, significantly contributing to improving the health and well-being of patients, bridging the gap from laboratory research to patient care.”


The Foundation presents the Lifetime Achievement Award in Clinical Research to Dr. Josep Tabernero for his distinguished career in clinical research and medical oncology, acknowledging his leadership in the development of molecular therapies against cancer and his significant contributions to translational medicine, as reflected in his extensive scientific work and his global impact on the oncological community.


Dr. Tabernero graduated in Medicine and Surgery with an Extraordinary Degree Award in 1987 and a Doctor of Medicine and Surgery from the Autonomous University of Barcelona. Dr. Josep Tabernero is currently the Head of the Medical Oncology Service at the Vall d’Hebron Hospital in Barcelona, Director of the Vall d’Hebron Institute of Oncology, and Head of the Molecular Cancer Therapy Research Unit at the Vall d’Hebron Hospital, a pioneering unit in Spain dedicated to the development of phase I clinical trials in molecular therapy. He is actively involved in translational research and pharmacokinetic and pharmacodynamic studies with new antineoplastic drugs. He is a professor at the University of Vic-Central University of Catalonia.


He participates in various international societies, such as the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO), of which he was president (2018-2019). He is the author of numerous scientific publications and co-author of many others (h-index of 122 and 89,995 citations).